These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 17628764)
1. [Anticoagulation in atrial fibrillation. ACTIVE Study (Arterial fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events)]. Meinertz T Internist (Berl); 2007 Aug; 48(8):874-5. PubMed ID: 17628764 [No Abstract] [Full Text] [Related]
2. Clopidogrel plus aspirin vs oral anticoagulation for atrial fibrillation: the ACTIVE W trial. DeSilvey DL Am J Geriatr Cardiol; 2006; 15(5):326-7. PubMed ID: 16957455 [No Abstract] [Full Text] [Related]
3. Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events. ; ; Connolly S; Yusuf S; Budaj A; Camm J; Chrolavicius S; Commerford PJ; Flather M; Fox KA; Hart R; Hohnloser S; Joyner C; Pfeffer M; Anand I; Arthur H; Avezum A; Bethala-Sithya M; Blumenthal M; Ceremuzynski L; De Caterina R; Diaz R; Flaker G; Frangin G; Franzosi MG; Gaudin C; Golitsyn S; Goldhaber S; Granger C; Halon D; Hermosillo A; Hunt D; Jansky P; Karatzas N; Keltai M; Lanas F; Lau CP; Le Heuzey JY; Lewis BS; Morais J; Morillo C; Oto A; Paolasso E; Peters RJ; Pfisterer M; Piegas L; Pipillis T; Proste C; Sitkei E; Swedberg K; Synhorst D; Talajic M; Trégou V; Valentin V; van Mieghem W; Weintraub W; Varigos J Am Heart J; 2006 Jun; 151(6):1187-93. PubMed ID: 16781218 [TBL] [Abstract][Full Text] [Related]
4. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. ; Connolly S; Pogue J; Hart R; Pfeffer M; Hohnloser S; Chrolavicius S; Pfeffer M; Hohnloser S; Yusuf S Lancet; 2006 Jun; 367(9526):1903-12. PubMed ID: 16765759 [TBL] [Abstract][Full Text] [Related]
5. The unmet need of patients with atrial fibrillation: AVERROES and the novel oral anticoagulants. Hart RG Int J Stroke; 2011 Jun; 6(3):207-8. PubMed ID: 21557805 [No Abstract] [Full Text] [Related]
6. Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). Healey JS; Hart RG; Pogue J; Pfeffer MA; Hohnloser SH; De Caterina R; Flaker G; Yusuf S; Connolly SJ Stroke; 2008 May; 39(5):1482-6. PubMed ID: 18323500 [TBL] [Abstract][Full Text] [Related]
7. Irbesartan in patients with atrial fibrillation. ; Yusuf S; Healey JS; Pogue J; Chrolavicius S; Flather M; Hart RG; Hohnloser SH; Joyner CD; Pfeffer MA; Connolly SJ N Engl J Med; 2011 Mar; 364(10):928-38. PubMed ID: 21388310 [TBL] [Abstract][Full Text] [Related]
8. Optimizing antiplatelet therapy in high-risk patients with atrial fibrillation: insights from Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE A). Seet RC; Chen CP Stroke; 2009 Dec; 40(12):3883-5. PubMed ID: 19875732 [No Abstract] [Full Text] [Related]
9. Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable. Connolly SJ; Eikelboom JW; Ng J; Hirsh J; Yusuf S; Pogue J; de Caterina R; Hohnloser S; Hart RG; Ann Intern Med; 2011 Nov; 155(9):579-86. PubMed ID: 22041946 [TBL] [Abstract][Full Text] [Related]
10. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. ; Connolly SJ; Pogue J; Hart RG; Hohnloser SH; Pfeffer M; Chrolavicius S; Yusuf S N Engl J Med; 2009 May; 360(20):2066-78. PubMed ID: 19336502 [TBL] [Abstract][Full Text] [Related]
11. Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure. Sandhu RK; Hohnloser SH; Pfeffer MA; Yuan F; Hart RG; Yusuf S; Connolly SJ; McAlister FA; Healey JS Stroke; 2015 Mar; 46(3):667-72. PubMed ID: 25628308 [TBL] [Abstract][Full Text] [Related]
12. [ASS plus clopidogrel in contraindication for marcumar]. Einecke D MMW Fortschr Med; 2009 Apr; 151(16):10-1. PubMed ID: 19658286 [No Abstract] [Full Text] [Related]
13. Atrial fibrillation, is warfarin the only option for stroke prevention? Khan M; Kamal AK J Pak Med Assoc; 2011 Mar; 61(3):301-2. PubMed ID: 21465955 [No Abstract] [Full Text] [Related]
14. Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation". Apostolakis S; Shantsila E; Lip GY; Lane DA Thromb Haemost; 2009 Nov; 102(5):914-5. PubMed ID: 19888529 [No Abstract] [Full Text] [Related]
16. Clopidogrel plus aspirin in atrial fibrillation. Goldstein LB N Engl J Med; 2009 Sep; 361(13):1313; author reply 1314-5. PubMed ID: 19780217 [No Abstract] [Full Text] [Related]
17. Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation". Healey JS Thromb Haemost; 2009 Nov; 102(5):912-3. PubMed ID: 19888528 [No Abstract] [Full Text] [Related]
18. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice. Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714 [No Abstract] [Full Text] [Related]
19. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention. Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760 [TBL] [Abstract][Full Text] [Related]
20. Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEAR. Jackson SL; Peterson GM; Bereznicki LR Am Heart J; 2005 Jan; 149(1):e3; author reply e4. PubMed ID: 15660026 [No Abstract] [Full Text] [Related] [Next] [New Search]